Long-term treatment with deutetrabenazine is associated with continued improvement in tardive dyskinesia (TD): Results from an open-label extension study

Authors
Category Primary study
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: c1cb592fd1a5ccae42ac434517e7272ed3961f81
First added on: Feb 11, 2025